Abstract:Metagenomic next-generation sequencing (mNGS) is a transformative approach in the diagnosis of infectious diseases, utilizing unbiased high-throughput sequencing to directly detect and characterize microbial genomes from clinical samples. This review comprehensively outlines the fundamental principles, sequencing workflow, and platforms utilized in mNGS technology. The methodological backbone involves shotgun sequencing of total nucleic acids extracted from diverse sample types, enabling simultaneous detection of bacteria, viruses, fungi, and parasites without prior knowledge of the infectious agent. Key advantages of mNGS include its capability to identify rare, novel, or unculturable pathogens, providing a more comprehensive view of microbial communities compared to traditional culture-based methods. Despite these strengths, challenges such as data analysis complexity, high cost, and the need for optimized sample preparation protocols remain significant hurdles. The application of mNGS across various systemic infections highlights its clinical utility. Case studies discussed in this review illustrate its efficacy in diagnosing respiratory tract infections, bloodstream infections, central nervous system infections, gastrointestinal infections, and others. By rapidly identifying pathogens and their genomic characteristics, mNGS facilitates timely and targeted therapeutic interventions, thereby improving patient outcomes and infection control measures. Looking ahead, the future of mNGS in infectious disease diagnostics appears promising. Advances in bioinformatics tools and sequencing technologies are anticipated to streamline data analysis, enhance sensitivity and specificity, and reduce turnaround times. Integration with clinical decision support systems promises to further optimize mNGS utilization in routine clinical practice. In conclusion, mNGS represents a paradigm shift in the field of infectious disease diagnostics, offering unparalleled insights into microbial diversity and pathogenesis. While challenges persist, ongoing technological advancements hold immense potential to consolidate mNGS as a pivotal tool in the armamentarium of modern medicine, empowering clinicians with precise, rapid, and comprehensive pathogen detection capabilities.

Non-Targeted RNA Sequencing: Towards the Development of Universal Clinical Diagnosis Methods for Human and Veterinary Infectious Diseases

Metagenome and detection of animal microbial pathogens

Application of Host-Depleted Nanopore Metagenomic Sequencing in the Clinical Detection of Pathogens in Pigs and Cats

High-Throughput Metagenomics for Identification of Pathogens in the Clinical Settings

Evaluating metagenomics and targeted approaches for diagnosis and surveillance of viruses

Targeting RNA with Next‐ and Third‐Generation Sequencing Improves Pathogen Identification in Clinical Samples

Next-Generation Sequencing for the Detection of Microbial Agents in Avian Clinical Samples

Clinical applications of metagenomics next-generation sequencing in infectious diseases

[The clinical application of targeted next-generation sequencing and metagenomics next-generation sequencing in pathogenic microorganism detection]

A streamlined clinical metagenomic sequencing protocol for rapid pathogen identification

Application of metagenomic next-generation sequencing in the diagnosis of infectious diseases

New-generation high-throughput technologies based 'omics' research strategy in human disease]

Translating RNA sequencing into clinical diagnostics: opportunities and challenges

Unbiased metagenomic detection of RNA viruses for rapid identification of viral pathogens in clinical samples

The application status of sequencing technology in global respiratory infectious disease diagnosis

Unified metagenomic method for rapid detection of microorganisms in clinical samples

Application of Metagenomic Sequencing for Pathogenic Diagnosis in Infectious Diseases

Metagenomic pathogen sequencing in resource-scarce settings: Lessons learned and the road ahead

mNGS in clinical microbiology laboratories: on the road to maturity

Validation of an unbiased metagenomic detection assay for RNA viruses in viral transport media and plasma

Clinical standardization of metagenomic next generation sequencing (mNGS) in the pathogen diagnosis